Market Overview:
The global vaginosis rapid testing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of vaginosis, rising awareness about early diagnosis and treatment of the condition, and technological advancements in rapid testing methods. Based on type, the global vaginosis rapid testing market is segmented into BVBlue technology and layered thin film technology. The BVBlue technology segment is expected to account for a larger share of the market in 2018 owing to its high accuracy and reliability. Based on application, the global vaginosis rapid testing market is segmented into hospitals, diagnostics centers, specialty clinics, and others (including research institutes and home care settings). The hospitals segment accounted for a larger share of the market in 2017 due to rising demand for early diagnosis and treatment of various diseases.
Product Definition:
A vaginosis rapid test is a diagnostic tool used to detect the presence of bacterial vaginosis (BV) in women. Bacterial vaginosis is a common condition caused by an overgrowth of certain bacteria in the vagina. Left untreated, BV can lead to other health complications. A rapid test offers a quick and easy way to determine if someone has BV, which can help with early treatment.
BVBlue Technology:
BV Blue is a patented technology of Becton, Dickinson and Company. It is used in the detection of bacterial vaginosis (BV) using rapid tests. The technology comprises detecting the presence or absence of bacteria in a sample by measuring their absorbance at certain wavelength. These tests are easy to use and provide accurate results within minutes which help healthcare professionals to take appropriate action for treatment as well as prevention purposes.
Layered Thin Film Technology:
The global market for vaginosis rapid testing is expected to witness significant growth over the forecast period. The key drivers attributing to its large share include growing prevalence of vaginal infections and increasing awareness among women population about the same. According to a research conducted by Michigan Medicine in 2015, it was estimated that around 12% of women are affected with bacterial vaginosis (BV) at some point in their lives.
Application Insights:
Based on application, the global vaginosis rapid testing market is segmented into hospitals, diagnostics centers, specialty clinics and others. Hospitals held the largest share in 2017 owing to factors such as high patient flow and volume of business done by these clinics. Diagnostic centers are expected to witness lucrative growth over the forecast period due to rising awareness about BV among women & their sexual partners which subsequently leads to treatment at these facilities. Specialty clinics are anticipated to be one of the fastest growing segments during the forecast period owing primarily because they provide a higher level of service than other types of healthcare facilities. These specialty clinics have highly skilled medical professionals who offer advanced diagnosis and treatment for various female reproductive system disorders including bacterial vaginosis (BV).
The others segment includes online services provided by private laboratories as well as non-clinical laboratories that offer BV rapid testing services online or through mobile applications without physical presence at an examination site in a clinical setting or hospital outpatient department respectively.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing awareness about BV, rising disposable income, and availability of effective treatment options in this region. In addition, high adoption rate of novel diagnostic technologies is expected to drive the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and growing target population base in this region. Moreover, economic development coupled with improvement in living standards has led people from lower socio-economic groups as well as women populations from rural areas towards urban centers for better employment opportunities and higher education degrees resulting into an increase in prevalence rates of BV among women especially those who have entered their reproductive years (15-44 years).
Growth Factors:
- Increasing incidence of vaginosis
- Growing awareness about the benefits of rapid testing for vaginosis
- Rising demand for convenient and easy-to-use diagnostic tests
- Technological advancements in rapid testing methods
- Growing number of private clinics and laboratories offering rapid testing services for vaginosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaginosis Rapid Testing Market Research Report
By Type
BVBlue Technology, Layered Thin Film Technology
By Application
Hospitals, Diagnostics Centers, Specialty Clinics, Others
By Companies
Medtronic, BD Diagnostics, Quidel, Mologic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Vaginosis Rapid Testing Market Report Segments:
The global Vaginosis Rapid Testing market is segmented on the basis of:
Types
BVBlue Technology, Layered Thin Film Technology
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostics Centers, Specialty Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- BD Diagnostics
- Quidel
- Mologic
Highlights of The Vaginosis Rapid Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- BVBlue Technology
- Layered Thin Film Technology
- By Application:
- Hospitals
- Diagnostics Centers
- Specialty Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaginosis Rapid Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vaginosis Rapid Testing is a home test that can be used to detect the presence of vaginosis. The test is simple and takes only a few minutes to complete.
Some of the major companies in the vaginosis rapid testing market are Medtronic, BD Diagnostics, Quidel, Mologic.
The vaginosis rapid testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vaginosis Rapid Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vaginosis Rapid Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vaginosis Rapid Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vaginosis Rapid Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vaginosis Rapid Testing Market Size & Forecast, 2018-2028
4.5.1 Vaginosis Rapid Testing Market Size and Y-o-Y Growth
4.5.2 Vaginosis Rapid Testing Market Absolute $ Opportunity
Chapter 5 Global Vaginosis Rapid Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Vaginosis Rapid Testing Market Size Forecast by Type
5.2.1 BVBlue Technology
5.2.2 Layered Thin Film Technology
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Vaginosis Rapid Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Vaginosis Rapid Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostics Centers
6.2.3 Specialty Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vaginosis Rapid Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vaginosis Rapid Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Vaginosis Rapid Testing Analysis and Forecast
9.1 Introduction
9.2 North America Vaginosis Rapid Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Vaginosis Rapid Testing Market Size Forecast by Type
9.6.1 BVBlue Technology
9.6.2 Layered Thin Film Technology
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Vaginosis Rapid Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostics Centers
9.10.3 Specialty Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Vaginosis Rapid Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Vaginosis Rapid Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Vaginosis Rapid Testing Market Size Forecast by Type
10.6.1 BVBlue Technology
10.6.2 Layered Thin Film Technology
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Vaginosis Rapid Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostics Centers
10.10.3 Specialty Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Vaginosis Rapid Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Vaginosis Rapid Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Vaginosis Rapid Testing Market Size Forecast by Type
11.6.1 BVBlue Technology
11.6.2 Layered Thin Film Technology
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Vaginosis Rapid Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostics Centers
11.10.3 Specialty Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Vaginosis Rapid Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Vaginosis Rapid Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Vaginosis Rapid Testing Market Size Forecast by Type
12.6.1 BVBlue Technology
12.6.2 Layered Thin Film Technology
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Vaginosis Rapid Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostics Centers
12.10.3 Specialty Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Vaginosis Rapid Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Vaginosis Rapid Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Vaginosis Rapid Testing Market Size Forecast by Type
13.6.1 BVBlue Technology
13.6.2 Layered Thin Film Technology
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Vaginosis Rapid Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostics Centers
13.10.3 Specialty Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vaginosis Rapid Testing Market: Competitive Dashboard
14.2 Global Vaginosis Rapid Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 BD Diagnostics
14.3.3 Quidel
14.3.4 Mologic
